Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ortho Clinical Diagnostics Announces Partnership With Thermo Fisher Scientific
2021-07-07 21:00
dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors
2021-07-07 20:00
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
2021-07-07 16:41
Elekta optimizes treatment times for cancer patients via proactive service innovation
2021-07-07 14:38
Innophys' MUSCLE SUIT Selling Steadily after Topping 20,000 Units
2021-07-07 14:00
CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy
2021-07-07 08:05
New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®
2021-07-07 06:34
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax
2021-07-07 01:43
Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody TST002
2021-07-06 21:36
RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally
2021-07-06 21:00
Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility
2021-07-06 21:00
Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market
2021-07-06 18:00
PolyU develops highly sensitive, microscopic optical fibre sensors with pioneering biomedical monitoring capability
2021-07-06 17:06
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate
2021-07-06 14:00
Bora Group announce the rebranding of Yuta Health to Bora Health
2021-07-06 13:31
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
2021-07-06 08:00
Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF)
2021-07-06 08:00
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
2021-07-06 07:00
SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting
2021-07-05 19:42
Octapharma's ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress
2021-07-05 19:30
1
273
274
275
276
277
533